A team at Western University discovered an interaction between proteins TDP43 and RGNEF which can neutralize the toxic effects of TDP43 in nerve cells. This discovery has shown positive outcomes in animal models by increasing lifespan and enhancing motor functions. The researchers aim to move this potential treatment to human clinical trials in the next three to five years, providing a ray of hope for ALS patients and their families.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode